CME
Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Proposition Surrounding the New Oral GnRH Antagonists
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Andrea S. Lukes, MD, MHSc, FACOG
By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnR